| A crucial role for macrophages in the pathology of K/B× N serum‐induced arthritis S Solomon, N Rajasekaran, E Jeisy‐Walder, SB Snapper, H Illges European journal of immunology 35 (10), 3064-3073, 2005 | 167 | 2005 |
| Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles G Spohn, K Schwarz, P Maurer, H Illges, N Rajasekaran, Y Choi, ... The Journal of Immunology 175 (9), 6211-6218, 2005 | 77 | 2005 |
| Strategic combinations: the future of oncolytic virotherapy with reovirus X Zhao, C Chester, N Rajasekaran, ZX He, HE Kohrt Molecular cancer therapeutics 15 (5), 767-773, 2016 | 71 | 2016 |
| Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment N Rajasekaran, C Chester, A Yonezawa, X Zhao, HE Kohrt ImmunoTargets and therapy, 91-100, 2015 | 65 | 2015 |
| Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis A Singh, N Rajasekaran, B Hartenstein, S Szabowski, M Gajda, P Angel, ... Arthritis research & therapy 15, 1-7, 2013 | 43 | 2013 |
| Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression JPO Hebb, AR Mosley, F Vences-Catalán, N Rajasekaran, A Rosén, ... Cancer Immunology, Immunotherapy 67 (1), 47-60, 2018 | 38 | 2018 |
| Carbon nanotubes—potent carriers for targeted drug delivery in rheumatoid arthritis C Kofoed Andersen, S Khatri, J Hansen, S Slott, R Pavan Parvathaneni, ... Pharmaceutics 13 (4), 453, 2021 | 30 | 2021 |
| Three BTK-specific inhibitors, in contrast to ibrutinib, do not antagonize rituximab-dependent NK-cell mediated cytotoxicity N Rajasekaran, M Sadaram, J Hebb, I Sagiv-Barfi, S Ambulkar, ... Blood 124 (21), 3118, 2014 | 29 | 2014 |
| Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis N Rajasekaran, S Solomon, T Watanabe, H Ohtsu, M Gajda, R Bräuer, ... International immunology 21 (11), 1263-1268, 2009 | 19 | 2009 |
| Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded … E Cluff, CC Magdaleno, E Fernandez, T House, S Swaminathan, ... Cancer Immunology, Immunotherapy, 1-17, 2022 | 18 | 2022 |
| The MHC class II cofactor HLA-DM interacts with Ig in B cells H Macmillan, MJ Strohman, S Ayyangar, W Jiang, N Rajasekaran, ... The Journal of Immunology 193 (6), 2641-2650, 2014 | 17 | 2014 |
| Comparison of transduction efficiency among various lentiviruses containing GFP reporter in bone marrow hematopoietic stem cell transplantation N Wang, N Rajasekaran, T Hou, L Lisowski, ED Mellins Experimental hematology 41 (11), 934-943, 2013 | 14 | 2013 |
| Obinutuzumab (GA101) is less prone to antagonism of immune effector function by ibrutinib than rituximab in vitro and in vivo S Herter, I Sagiv-Barfi, C Chester, M Sadaram, J Hebb, DK Czerwinski, ... Blood 124 (21), 1765, 2014 | 13 | 2014 |
| Hypoxia-Inducible Factor-1α is upregulated in Natural Killer cells by Interleukin-2 and hypoxia via PI3K/mTOR signaling pathway ER Cluff, J Nolan, C Collins, A Varadaraj, N Rajasekaran The Journal of Immunology 202 (1_Supplement), 194.37-194.37, 2019 | 12 | 2019 |
| Multicohort analysis identifies monocyte gene signatures to accurately monitor subset-specific changes in human diseases F Vallania, L Zisman, C Macaubas, SC Hung, N Rajasekaran, S Mason, ... Frontiers in Immunology 12, 659255, 2021 | 11 | 2021 |
| I-Ag7 is subject to post-translational chaperoning by CLIP CH Rinderknecht, N Lu, O Crespo, P Truong, T Hou, N Wang, ... International immunology 22 (8), 705-716, 2010 | 10 | 2010 |
| Reduced locomotor activity correlates with increased severity of arthritis in a mouse model of antibody-induced arthritis N Rajasekaran, R Tran, C Pascual, X Xie, ED Mellins Open journal of rheumatology and autoimmune diseases 4 (1), 62, 2014 | 7 | 2014 |
| HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl2 C Magdaleno, L Dixon, N Rajasekaran, A Varadaraj Scientific Reports 10 (1), 18560, 2020 | 6 | 2020 |
| Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 Ab A Yonezawa, C Chester, N Rajasekaran, HE Kohrt Chinese Clinical Oncology 5 (1), 5-5, 2016 | 6 | 2016 |
| B6. g7 mice reconstituted with BDC2· 5 non-obese diabetic (BDC2· 5NOD) stem cells do not develop autoimmune diabetes N Rajasekaran, N Wang, Y Hang, C Macaubas, C Rinderknecht, ... Clinical & Experimental Immunology 174 (1), 27-37, 2013 | 6 | 2013 |
